Arthritis Research UK Gout Treatment Trial - Phase 2

Last updated: January 4, 2017
Sponsor: University of Nottingham
Overall Status: Completed

Phase

N/A

Condition

Joint Injuries

Arthritis And Arthritic Pain (Pediatric)

Collagen Vascular Diseases

Treatment

N/A

Clinical Study ID

NCT01477346
11115
  • Ages > 21
  • All Genders

Study Summary

The purpose of this study is to determine in community-derived patients with gout the effectiveness, and cost effectiveness, of a nurse-led complex intervention that reflects recommended best practice (including patient information concerning gout, its prognosis and its non-pharmacological and drug options).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of gout

  • At least one acute attack of gout within previous 12 months

Exclusion

Exclusion Criteria:

  • Inability to give informed consent and known terminal or mental illness

Study Design

Total Participants: 517
Study Start date:
March 01, 2013
Estimated Completion Date:
October 31, 2016

Connect with a study center

  • Academic Rheumatology, University of Nottingham

    Nottingham, NG5 1PB
    United Kingdom

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.